摘要
肝癌是常见的恶性肿瘤之一,严重威胁人类健康[1]。肝细胞癌作为肝癌的主要类型,在外科切除术后极易复发和转移。肿瘤干细胞理论认为肝前体细胞异常分化为肝癌干细胞(live cancer stem cell ,LCSC),从而诱发肝癌的发生、发展[2]。
出处
《中华消化杂志》
CAS
CSCD
北大核心
2015年第9期643-645,共3页
Chinese Journal of Digestion
参考文献5
-
1王明达,王超,吴孟超.肝前体细胞生物学特性及调控机制的研究进展[J].第二军医大学学报,2012,33(10):1129-1134. 被引量:1
-
2游苏宁.十年漫漫抗癌路 医患冷暖自心知[J].中华消化杂志,2013,33(11):721-723. 被引量:1
-
3郑天郢,张昕,王永刚,高雪芹,张华宁.白细胞介素-8对不同转移潜能肝癌细胞增殖及侵袭的影响[J].中华消化杂志,2007,27(5):350-351. 被引量:2
-
4Bhavna Rani,Yuan Cao,Andrea Malfettone,Ciprian Tomuleasa,Isabel Fabregat,Gianluigi Giannelli.Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma[J].World Journal of Gastroenterology,2014,20(15):4128-4140. 被引量:6
-
5程海林,田德安,刘梅,陈孝平,但自力,王波,黎培元,何春萍.解聚素金属蛋白酶和肝素结合表皮生长因子在肝癌组织中的分布及临床意义[J].中华消化杂志,2007,27(7):485-486. 被引量:2
二级参考文献23
-
1Aránzazu Sánchez,Isabel Fabregat.Growth factor-and cytokine-driven pathways governing liver stemness and differentiation[J].World Journal of Gastroenterology,2010,16(41):5148-5161. 被引量:7
-
2Koch AE,Polverini PJ,Kunkel SL,et al.Interleukin-8 as a macrophage-derived mediator of angiogenesis.Science,1992,258:1798-1801. 被引量:1
-
3Li A,Varney ML,Singh RK.Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials.Clin Cancer Res,2001,7:3298-3304. 被引量:1
-
4De Larco JE,Wuertz BR,Rosner KA,et al.A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.Am J Pathol,2001,158:639-646. 被引量:1
-
5Kubo F,Ueno S,Hiwatashi K,et al.Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis.Ann Surg Oncol,2005,12:800-807. 被引量:1
-
6Huang S,Mills L,Mian B,et al.Fully humanized neutralizing antibodies to interleukin-8(ABX-IL8)inhibit angiogenesis,tumor growth,and metastasis of human melanoma.Am J Pathol,2002,161:125-134. 被引量:1
-
7Adam RM, Danciu T, McLellan DL, et al. A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma. Cancer Res, 2003, 63:484-490. 被引量:1
-
8Le Pabie H, Bonnier D, Wewer UM, et al. ADAM12 in human liver cancers: TGF-β-regulated expression in stellate cells is associated with matrix remodeling. Hepatology, 2003, 37:1056-1066. 被引量:1
-
9Iba K, Albreehtsen R, Gilpin BJ, et al. Cysteine-rieh domain of human ADAM 12(meltrin α) supports tumor cell adhesion. Am J Pathol, 1999, 154:1489-501. 被引量:1
-
10Braun AH, Robert J. Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last. Clin Cancer Res, 2005, 11:4639-4643. 被引量:1
共引文献7
-
1刘静,王健.HBV感染胎盘与IL-8表达[J].中国微生态学杂志,2012,24(5):478-480.
-
2梁婷,安明超.中药干预肿瘤患者放化疗中免疫功能临床研究进展[J].新中医,2019,51(1):51-55. 被引量:7
-
3谢雨潇,廖锐,潘龙,范凯,彭聪,杜成友.肝星状细胞条件培养基激活ERK1/2通路诱导肝癌细胞增殖及上皮间质转化[J].细胞与分子免疫学杂志,2017,33(2):210-214. 被引量:5
-
4王瑶,彭芳.中药对肝癌免疫微环境影响的研究进展[J].医学综述,2017,23(7):1342-1345. 被引量:4
-
5郭林英,余腾骅,张光君,尹恒,柳满然,涂刚.肿瘤相关成纤维细胞中GPER介导HMGB1外分泌促进乳腺癌MCF-7细胞自噬及增殖[J].肿瘤,2017,37(5):448-456. 被引量:8
-
6张杨,杨琰,张翌,曹钧.ADAM12在原发性肝癌侵袭性中的作用及机制研究[J].腹部外科,2019,32(3):220-224. 被引量:2
-
7Rui Peng,Guang-Xi Zhao,Jing Li,Yu Zhang,Xi-Zhong Shen,Ji-Yao Wang,Jian-Yong Sun.Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo[J].World Journal of Gastroenterology,2016,22(12):3341-3354. 被引量:4
同被引文献37
-
1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J1. CA Cancer J Clin,2015,65(2):87-108. DOI:10. 3322/caac. 21262. 被引量:1
-
2Dindo D, Demartines N, Clavien PA. Classification of surgical complications : a new proposal with evaluation in a cohort of 6336 patients and results of a survey [ J ]. Ann Surg, 2004,240 ( 2 ) : 205-213. 被引量:1
-
3Capussotti L, Viganb L, Giuliante F, et al. Liver dysfunction and sepsis determine operative mortality after liver resection[J]. Br J Surg,2009,96( 1 ) :88-94. DOI: 10. 1002/bjs. 6429. 被引量:1
-
4Itoh S, Uchiyama H, Kawanaka H, et al. Characteristic risk fac- tors in cirrhotic patients for posthepatectomy complications: corn-parison with noncirrhotic patients [ J ]. Am Surg, 2014,80 ( 2 ) : 166-170. 被引量:1
-
5Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5 : an accurate predictor of liver failure and death after hepatectomy [ J ]. Ann Surg, 2005,242 ( 6 ) : 824-829. DOI : 10. 1097/01. sla. 0000189131. 90876.9e. 被引量:1
-
6Mayo SC, Shore AD, Nathan H, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion[ J]. HPB (Oxford) ,2011,13 (7) : 473-482. DOI : 10.1111/j. 1477-2574. 2011. 00326. x. 被引量:1
-
7Kim JM, Kwon CH, Joh JW, et al. Differences between hepato- cellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis [ J ]. Ann Surg Oncol, 2014,21 ( 2 ) : 458- 465. DO! : 10. 1245/s10434-013-3302-1. 被引量:1
-
8Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioper- ative outcome after hepatic resection : analysis of 1,803 consecu- tive cases over the past decade [ J ]. Ann Surg, 2002,236 (4) : 397-407. DOI:10. 1097/01. SLA. 0000029003. 66466. B3. 被引量:1
-
9Kawano Y, Sasaki A, Kai S, et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomi- tant esophageal varices in patients with cirrhosis [ J ]. Ann Surg 0ncol,2008, 15 (6) : 1670-1676. DOI: 10. 1245/s10434-008- 9880-7. 被引量:1
-
10van den Brock MA, Olde DSW, Dejong CH, et al. Liver failure after partial hepatic resection : definition, pathophysiology, risk factors and treatment [ J ]. Liver Int,2008,28 (6) :767-780. DOI : 10.1111/j. 1478-3231. 2008. 01777. x. 被引量:1
引证文献3
-
1韩秀国,马宽生,夏锋,闫军,冯晓彬,肖森林,李晓武.肝硬化肝癌和无肝硬化肝癌患者围术期肝衰竭和死亡的相关因素分析[J].中华消化外科杂志,2016,15(6):605-614. 被引量:45
-
2陈锐俊,薛梅,高燕灵,李楚云.乙型肝炎相关肝硬化肝癌和无肝硬化肝癌患者围术期情况及肝衰竭危险因素分析[J].河北医科大学学报,2018,39(6):640-644. 被引量:21
-
3胡贻隽,刘淑鹏,程凯,徐贵霞,胡晶晶,刘善荣.长链非编码RNA-8439促进肝癌细胞多能因子nanog的表达[J].第二军医大学学报,2018,39(12):1309-1316. 被引量:1
二级引证文献65
-
1王欣,王秀云,王丰艳,徐洁.血清AFP和CA199浓度与肝癌合并肝硬化患者肝脏切除后转归的关系[J].湖南师范大学学报(医学版),2021,18(4):248-251. 被引量:5
-
2景卫.探讨中西医结合治疗乙型肝炎及早期肝硬化对其康复情况影响[J].反射疗法与康复医学,2020(12):76-78. 被引量:1
-
3陈漪,周俭,樊嘉,王征,史颖弘,王晓颖,葛宁灵,任正刚.术中射频消融治疗合并重度肝硬化肝细胞癌的临床疗效及预后因素分析[J].中华消化外科杂志,2017,16(2):159-163. 被引量:16
-
4汪珍光,傅思源,林川,潘泽亚,刘辉,杨远,章一琎,蒋贝格,周伟平,吴孟超.经前入路肝尾状叶全切除术治疗累及腔静脉旁部肝肿瘤的临床疗效[J].中华消化外科杂志,2017,16(2):195-200. 被引量:4
-
5黄允,李艳,彭锐,戴雯.HBV感染致肝损伤患者CRP,hsCRP和SAA临床价值的探讨[J].现代检验医学杂志,2017,32(2):49-52. 被引量:13
-
6刘金忠,郑福昌.原发性肝癌合并肝硬化与无肝硬化患者的围术期并发症相关因素分析[J].中国医师杂志,2017,19(6):937-939. 被引量:6
-
7汪平,鲍鹰.疏肝理气汤联合肝射频消融对晚期肝癌预后的影响[J].中国现代医生,2017,55(23):112-115. 被引量:5
-
8曹国良,蔡庆,李幼安,张起帆,周杰.肝细胞癌微血管侵犯的危险因素分析及预后[J].中华消化外科杂志,2017,16(10):1048-1052. 被引量:20
-
9王明友.静脉曲张程度、Child评分预测食管胃静脉曲张破裂出血患者再出血的临床价值[J].世界华人消化杂志,2017,25(26):2387-2393. 被引量:6
-
10朱明芹.分层护理干预在肝硬化患者中的应用[J].实用医院临床杂志,2017,14(6):261-263. 被引量:7
-
1芦永良,申利红,李红丽,胡代曦,张锡峰,胡斌,冯涛,黄佳祎.稳定表达HBx的肝前体细胞株的构建及其对增殖的影响[J].细胞与分子免疫学杂志,2013,29(3):256-260. 被引量:4
-
2王伟,何理盛,林志雄.胶质瘤干细胞生物学特性研究[J].中华神经外科疾病研究杂志,2009,8(3):283-285. 被引量:8
-
3郑璐玉,张旭.肿瘤干细胞的研究进展[J].现代肿瘤医学,2009,17(5):959-961. 被引量:3
-
4陈志刚,黄建.结肠癌干细胞研究进展[J].实用肿瘤杂志,2010,25(1):103-105. 被引量:5
-
5彭广新,李大鹏.肿瘤干细胞与恶性肿瘤的靶向治疗[J].中国肿瘤临床,2006,33(7):418-420. 被引量:4
-
6李桂芝,刘丽红,卢恩英.凋亡抑制基因Survivin与乳腺癌致病的研究进展[J].家庭心理医生,2014,10(12):103-103.
-
7“仁济”首次成功分离卵巢癌干细胞[J].上海交通大学学报(医学版),2008,28(9):1190-1190.
-
8文朝阳,史争鸣,赵娜,薛晓伟,丰平,王学江.氧化损伤对骨髓源性肝前体细胞恶性转化的影响[J].解剖学报,2015,46(6):780-784.
-
9胡代曦,张锡峰,张超,钟沁,冯涛,黄佳祎.Wnt3诱导小鼠肝前体细胞上皮-间质转化[J].第二军医大学学报,2013,34(11):1166-1170. 被引量:2
-
10徐伟,李高峰,李权,王杰,吴东.肝癌肿瘤异质性的临床新进展[J].肝胆胰外科杂志,2016,28(1):84-86. 被引量:12